Gallic acid, one of the components in many plant tissues, is a potential inhibitor for insulin amyloid fibril formation

European Journal of Medicinal Chemistry

Volumn 85, Issue , 2014, Pages 352-358

  Jayamani, Jayaraman ^a,b   Shanmugam, Ganesh ^a,b  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

Amyloid; Fibril; Gallic acid; Inhibition; Insulin

Indexed keywords

AMYLOID; GALLIC ACID; INSULIN; THIOFLAVINE; PLANT EXTRACT;

ALPHA HELIX; ARTICLE; ATOMIC FORCE MICROSCOPY; BETA SHEET; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG EFFECT; IN VITRO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PH; PLANT LEAF; PLANT TISSUE; SPECTROSCOPY; TURBIDITY; DRUG MECHANISM; OPTICAL DENSITY; PROTEIN AGGREGATION; PROTEIN SECONDARY STRUCTURE; ROOM TEMPERATURE; STEADY STATE; CHEMISTRY; DRUG EFFECTS; PROTEIN MULTIMERIZATION;

AMYLOID; GALLIC ACID; INSULIN; PLANT EXTRACTS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY;

EID: 84905708160     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.07.111     Document Type: Article

References (64)

1. A. Lorenzo, and B.A. Yankner β-amyloid neurotoxicity requires fibril formation and is inhibited by congo red Proc. Natl. Acad. Sci. USA 91 1994 12243 12247 (Pubitemid 24368641)
2. P.K. Nandi Protein conformation and disease Vet. Res. 27 1996 373 382 (Pubitemid 126496651)
3. D. Foguel, M.C. Suarez, A.D. Ferrao-Gonzales, T.C. Porto, L. Palmieri, C.M. Einsiedler, L.R. Andrade, H.A. Lashuel, P.T. Lansbury, J.W. Kelly, and J.L. Silva Dissociation of amyloid fibrils of α-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities Proc. Natl. Acad. Sci. USA 100 2003 9831 9836 (Pubitemid 37087027)
4. D.J. Selkoe Folding proteins in fatal ways Nature 426 2003 900 904 (Pubitemid 38056883)
5. D.M. Walsh, and D.B. Teplow Alzheimer's disease and the amyloid β-protein Prog. Mol. Biol. Trans. Sci. 107 2012 101 124
6. V.L. Villemagne, S. Burnham, P. Bourgeat, B. Brown, K.A. Ellis, O. Salvado, C. Szoeke, S.L. Macaulay, R. Martins, P. Maruff, D. Ames, C.C. Rowe, and C.L.L. Masters Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study Lancet Neurol. 12 2013 357 367
7. E.D. Eanes, and G.G. Glenner X-ray diffraction studies on amyloid filaments J. Histochem Cytochem. 16 1968 673 677
8. M. Sunde, and C. Blake The structure of amyloid fibrils by electron microscopy and x-ray diffraction Adv. Protein Chem. 50 1997 123 159 (Pubitemid 27449487)
9. S. Hoyer Risk factors for Alzheimer's disease during aging. Impacts of glucose/energy metabolism J. Neural Transm. Suppl. 54 1998 187 194 (Pubitemid 28539355)
10. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2973 2002 53 56
11. C. Weyer, C. Bogardus, D.M. Mott, and R.E. Pratley The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus J. Clin. Invest. 104 1999 787 794 (Pubitemid 29536364)
12. A.E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R.A. Rizza, and P.C. Butler β-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes Diabetes 52 2003 102 110 (Pubitemid 36042113)
13. E. Rhoades, J. Agarwal, and A. Gafni Aggregation of an amyloidogenic fragment of human islet amyloid polypeptide Biochim. Biophys. Acta. 1476 2000 230 238 (Pubitemid 30089188)
14. L. Nielsen, R. Khurana, A. Coats, S. Frokjaer, J. Brange, S. Vyas, V. Uversky, and A.L. Fink Effects of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism Biochemistry 40 2001 6036 6046 (Pubitemid 32466306)
15. M.R. Krebs, D.K. Wilkins, E.W. Chung, M.C. Pitkeathly, A.K. Chamberlain, J. Zurdo, C.V. Robinson, and C.M. Dobson Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the β-domain J. Mol. Biol. 300 2000 541 549
16. N. Hirota-Nakaoka, K. Hasegawa, H. Naiki, and Y. Goto Dissolution of β2-microglobulin amyloid fibrils by dimethylsulfoxide J. Biochem 134 2003 159 164 (Pubitemid 37071192)
17. A. Arora, C. Ha, and C.B. Park Insulin amyloid fibrillation at above 100°C: new insights into protein folding under extreme temperatures Protein Sci. 13 2004 2429 2436 (Pubitemid 39128863)
18. S.-H. Wang, A.-Y. Dong, and Y. Sun Effect of (-)-epigallocatechin-3- gallate on human insulin fibrillation/aggregation kinetics Biochem Biophys. Res. Commun. 63 2012 38 49
19. J. Ehrlich, and I.M. Ratner Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and non-diabetic individuals Am. J. Pathol. 38 1961 49 59
20. S. Storkel, H.M. Schneider, H. Muntefering, and S. Kashiwagi Iatrogenic, insulin-dependent, local amyloidosis Lab. Invest. 48 1983 108 111 (Pubitemid 13110940)
21. M.J. Burke, and M.A. Rougvie Cross-β protein structures. I. Insulin fibrils Biochemistry 11 1972 2435 2439
22. M.A. Weiss, D.T. Nguyen, I. Khait, K. Inouye, B.H. Frank, M. Beckage, E. O'Shea, S.E. Shoelson, M. Karplus, and L.J. Neuringer Two-dimensional NMR and photo-CIDNP studies of the insulin monomer: assignment of aromatic resonances with application to protein folding, structure, and dynamics Biochemistry 28 1989 9855 9873 (Pubitemid 20022335)
23. D.F. Waugh A fibrous modification of insulin. I. The heat precipitate of insulin J. Am. Chem. Soc. 68 1946 247 250
24. I. Langmuir, and D.F. Waugh Pressure-soluble and pressure displaceable components of mono layers of native and denatured proteins J. Am. Chem. Soc. 62 1940 2771 2793
25. D.F. Waugh The properties of protein fibers produced reversibly from soluble protein molecules Am. J. Physiol. 133 1941 484 485
26. M.J. Adams, T.L. Blundell, E.J. Dodson, G.G. Dodson, M. Vijayan, E.N. Baker, M.M. Harding, D.C. Hodgkin, B. Rimmer, and S. Sheat Structure of 2 zinc insulin crystals Nature 224 1969 491 495
27. J. Brange, G.G. Dodson, D.J. Edwards, P.H. Holden, and J.L. Whittingham Model of insulin fibrils derived from the X-ray crystal structure of a monomeric insulin (Despentapeptide insulin), proteins: structure Funct. Genet. 27 1997 507 516 (Pubitemid 27212350)
28. V. Banerjee, and K.P. Das Modulation of pathway of insulin fibrillation by a small molecule helix inducer 2,2,2-trifluoroethanol Colloid. Surf. B: Biointerf. 92 2012 142 150
29. L. Nielsen, S. Frokjaer, J. Brange, V.N. Uversky, and A.L. Fink Probing the mechanism of insulin fibril formation with insulin mutants Biochemistry 40 2001 8397 8409 (Pubitemid 32661900)
30. M. Mauro, E.F. Craparo, A. Podesta, D. Bulone, R. Carrotta, V. Martorana, G. Tiana, and P.L. San Biagio Kinetics of different processes in human insulin amyloid formation J. Mol. Biol. 366 2007 258 274 (Pubitemid 46123327)
31. A. Loksztejn, and W. Dzwolak Vortex-induced formation of insulin amyloid superstructures probed by time-lapse atomic force microscopy and circular dichroism spectroscopy J. Mol. Biol. 395 2010 643 655
32. Y. Porat, A. Abramowitz, and E. Gazit Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism Chem. Biol. Drug. Des. 67 2006 27 37 (Pubitemid 43881385)
33. M. Stefani, and S. Rigacci Protein folding and aggregation into amyloid: the interference by natural phenolic compounds Int. J. Mol. Sci. 14 2013 12411 12457
34. U. Peters, C. Poole, and L. Arab Does tea affect cardiovascular disease? A meta-analysis Am. J. Epidemiol. 154 2001 495 503 (Pubitemid 32867948)
35. P.C. Hollman, E.J. Feskens, and M.B. Katan Tea flavonols in cardiovascular disease and cancer epidemiology Proc. Soc. Exp. Biol. Med. 220 1999 198 202
36. Y.J. Wang, P. Thomas, J.H. Zhong, F.F. Bi, S. Kosaraju, A. Pollard, M. Fenech, and X.F. Zhou Consumption of grape seed extract prevents amyloid-β deposition and attenuates inflammation in brain of an Alzheimer's disease mouse Neurotox. Res. 15 2009 3 14
37. Y. Liu, T.L. Pukala, I.F. Musgrave, D.M. Williams, F.C. Dehle, and J.A. Carver Gallic acid is the major component of grape seed extract that inhibits amyloid fibril formation Bioorg Med. Chem. Lett. 23 2013 6336 6340
38. S. Bastianetto, Z.X. Yao, V. Papadopoulos, and R. Quirion Neuroprotective effects of green and black teas and their catechin gallate esters against β-amyloid-induced toxicity Eur. J. Neurol. 23 2006 55 64
39. Y. Liu, J.A. Carver, A.N. Calabrese, and T.L. Pukala Gallic acid interacts with α-synuclein to prevent the structural collapse necessary for its aggregation Biochim. Biophys. Acta Proteins Proteom. 1844 2014 1481 1485
40. J.D. Harper, C.M. Lieber, and P.T. Lansbury Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein Chem. Biol. 4 1997 951 959 (Pubitemid 28050379)
41. H.K. Blackley, G.H. Sanders, M.C. Davies, C.J. Roberts, S.J. Tendler, and M.J. Wilkinson In-situ atomic force microscopy study of β-amyloid fibrillization J. Mol. Biol. 298 2000 833 840
42. A.K. Chamberlain, C.E. MacPhee, J. Zurdo, L.A. Morozova-Roche, H.A. Hill, C.M. Dobson, and J.J. Davis Ultrastructural organization of amyloid fibrils by atomic force microscopy Biophys. J. 79 2000 3282 3293
43. N. Norlin, M. Hellberg, A. Filippov, A.A. Sousa, G. Gröbner, R.D. Leapman, N. Almqvist, and O.N. Antzutkin Aggregation and fibril morphology of the Arctic mutation of Alzheimer's Aβ peptide by CD, TEM, STEM and in situ AFM J. Struct. Biol. 180 2012 174 189
44. H. Naiki, K. Higuchi, M. Hosokawa, and T. Takeda Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T Anal. Biochem. 177 1989 244 249 (Pubitemid 19088253)
45. J.R. Hobbs, and A.D. Morgan Fluorescence microscopy with thioflavine-T in the diagnosis of amyloid J. Pathol. Bacteriol. 86 1963 437 442
46. S.M. Saeed, and G. Fine Thioflavin-T for amyloid detection Am. J. Clin. Pathol. 47 1967 588 593
47. R. Khurana, C. Coleman, C. Ionescu-Zanetti, S.A. Carter, V. Krishna, R.K. Grover, R. Roy, and S. Singh Mechanism of thioflavin T binding to amyloid fibrils J. Struct. Biol. 151 2005 229 238 (Pubitemid 41338730)
48. N.J. Greenfield Using circular dichroism spectra to estimate protein secondary structure Nat. Protoc. 1 2006 2876 2890
49. G.D. Fasman Circular Dichroism and the Conformational Analysis of Biomolecules 1996 Plenum Press New York
50. D.O. ElAgnaf, D. Guthrie, D. Walsh, and G. Irvine The influence of the central region containing residues 19-25 on the aggregation properties and secondary structure of Alzheimer's β-amyloid peptide Eur. J. Biochem 256 1998 560 569 (Pubitemid 28440422)
51. A. Ahmad, V.N. Uversky, D. Hong, and A.L. Fink Early events in the fibrillation of monomeric insulin J. Biol. Chem. 280 2005 42669 42675 (Pubitemid 43049225)
52. W. Dzwolak, R. Ravindra, J. Lendermann, and R. Winter Aggregation of bovine insulin probed by DSC/PPC calorimetry and FTIR spectroscopy Biochemistry 42 2003 11347 11355 (Pubitemid 37158902)
53. M.R. Nilsson Techniques to study amyloid fibril formation in vitro Methods 34 2004 151 160 (Pubitemid 38993215)
54. S. Krimm, and J. Bandekar Vibrational spectroscopy and conformation of peptides, polypeptide and proteins Adv. Protein Chem. 38 1986 181 364
55. W.K. Surewicz, H.H. Mantsch, and D. Chapman Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment Biochemistry 32 1993 389 394 (Pubitemid 23034873)
56. Z. Lai, W. Colon, and J.W. Kelly The acid mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid Biochemistry 25 1996 6470 6482 (Pubitemid 26164080)
57. K. Ono, Y. Yoshiike, A. Takashima, K. Hasegawa, H. Naiki, and M. Yamada Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro implications for the prevention and therapeutics of Alzheimer's disease J. Neurochem. 87 2003 172 181 (Pubitemid 37210651)
58. K. Ono, K. Hasegawa, H. Naiki, and M. Yamada Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's β-amyloid fibrils in vitro Biochim. Biophys. Acta 1690 2004 193 202 (Pubitemid 39423614)
59. W.G. Turnell, and J.T. Finch Binding of the dye congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid-forming peptide sequences J. Mol. Biol. 227 1992 1205 1223
60. T. Kálai, J. Petrlova, M. Balog, H.H. Aung, J.C. Voss, and K. Hideg Synthesis and study of 2-amino-7-bromofluorenes modified with nitroxides and their precursors as dual anti-amyloid and antioxidant active compounds Eur. J. Med. Chem. 46 2011 1348 1355
61. Y.-P. Li, F.X. Ning, M.B. Yang, Y.-C. Li, M.-H. Nie, T.-M. Ou, J.H. Tan, S.-L. Huang, D. Li, L.-Q. Gu, and Z.-S. Huang Syntheses and characterization of novel oxoisoaporphine derivatives as dual inhibitors for cholinesterases and amyloid β aggregation Eur. J. Med. Chem. 46 2011 1572 1581
62. Y.-P. Chen, Z.-Y. Zhang, Y.-P. Li, D. Li, S.-L. Huang, L.-Q. Gu, J. Xu, and Z.-S. Huang Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-β aggregation and 5-lipoxygenase Eur. J. Med. Chem. 66 2013 22 31
63. L.O. Tjernberg, J. Näslund, F. Lindqvist, J. Johansson, A.R. Karlström, J. Thyberg, L. Terenius, and C. Nordstedt Arrest of β-amyloid fibril formation by a pentapeptide ligand J. Biol. Chem. 271 1996 8545 8548 (Pubitemid 26123269)
64. Y. Miura, C. You, and R. Ohnishi Inhibition of Alzheimer amyloid aggregation by polyvalent trehalose Sci. Technol. Adv. Mater. 9 2008 24407